134 related articles for article (PubMed ID: 11068620)
1. [Cancers of the cavum].
Marandas P; Marandas N
Rev Prat; 2000 Sep; 50(14):1556-61. PubMed ID: 11068620
[TBL] [Abstract][Full Text] [Related]
2. [Prognostic impact of plasma Epstein-Barr virus DNA concentration on distant metastasis in nasopharyngeal carcinoma].
Hou X; Zhang L; Zhao C; Li S; Lu LX; Han F; Shao JY; Huang PY
Ai Zheng; 2006 Jul; 25(7):785-92. PubMed ID: 16831265
[TBL] [Abstract][Full Text] [Related]
3. [Important prognostic factors in patients with skull base erosion from nasopharyngeal carcinoma after radiotherapy].
Hu Y; Lu T; Mai W; Han F; Huang Y; Liu H; Zhang E
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Dec; 36(6):463-7. PubMed ID: 12761966
[TBL] [Abstract][Full Text] [Related]
4. A prospective study of p53 expression and its correlation with clinical response of radiotherapy in nasopharyngeal carcinoma.
Ho KY; Kuo WR; Chai CY; Tsai SM; Sheu SH; Wu SC; Juan KH
Laryngoscope; 2001 Jan; 111(1):131-6. PubMed ID: 11192881
[TBL] [Abstract][Full Text] [Related]
5. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
[TBL] [Abstract][Full Text] [Related]
6. Survival study and treatment strategy for second primary malignancies in patients with head and neck squamous cell carcinoma and nasopharyngeal carcinoma.
Tsou YA; Hua CH; Tseng HC; Lin MH; Tsai MH
Acta Otolaryngol; 2007 Jun; 127(6):651-7. PubMed ID: 17503236
[TBL] [Abstract][Full Text] [Related]
7. Concurrent chemo-radiotherapy for nasopharyngeal carcinoma.
Okita J; Hatta C; Terada T; Saeki N; Ogasawara H; Kakibuchi M; Kamikonya N; Sakagami M
Auris Nasus Larynx; 2004 Mar; 31(1):43-7. PubMed ID: 15041053
[TBL] [Abstract][Full Text] [Related]
8. Nasopharyngeal carcinoma in childhood and adolescence: a single institution's experience with treatment modalities during the last 15 years.
Polychronopoulou S; Kostaridou S; Panagiotou JP; Stefanaki K; Papadakis V; Florentin L; Houlakis M; Christopoulos G; Haidas S
Pediatr Hematol Oncol; 2004; 21(5):393-402. PubMed ID: 15205082
[TBL] [Abstract][Full Text] [Related]
9. Molecular diagnosis of nasopharyngeal carcinoma using detection of Epstein-Barr virus latent membrane protein-1 gene in cervical metastatic lymph nodes.
Khademi B; Mahmoudi J; Monabati A; Maghsoudi B; Ashraf MJ; Mohammadianpanah M; Tabibi N; Valibeigi B; Abedi E
Am J Otolaryngol; 2009; 30(2):95-100. PubMed ID: 19239950
[TBL] [Abstract][Full Text] [Related]
10. Malignancies of the ear in irradiated patients of nasopharyngeal carcinoma.
Lo WC; Ting LL; Ko JY; Lou PJ; Yang TL; Chang YL; Wang CP
Laryngoscope; 2008 Dec; 118(12):2151-5. PubMed ID: 18948828
[TBL] [Abstract][Full Text] [Related]
11. [Correlation of DNA ploidy in fresh tumor tissues to prognosis of nasopharyngeal carcinoma].
Han F; Wang HY; Xia YF; Liu MZ; Zhao C; Lu TX
Ai Zheng; 2007 Sep; 26(9):1015-9. PubMed ID: 17927864
[TBL] [Abstract][Full Text] [Related]
12. [Undifferentiated carcinoma of the nasopharynx: epidemiological, clinical and therapeutic aspects].
Fandi A; Yanes B; Taamma A; Azli N; Armand JP; Dupuis O; Eschwège F; Schwaab G; Cvitkovic E
Bull Cancer; 1994 Jul; 81(7):571-86. PubMed ID: 7742599
[TBL] [Abstract][Full Text] [Related]
13. [Clinical peculiarities of nasopharyngeal cancers].
Brugère J
Bull Cancer; 1976; 63(3):427-32. PubMed ID: 1000092
[TBL] [Abstract][Full Text] [Related]
14. A retrospective cohort study of nasopharyngeal adenocarcinoma: a rare histological type of nasopharyngeal cancer.
Guo ZM; Liu WW; He JH
Clin Otolaryngol; 2009 Aug; 34(4):322-7. PubMed ID: 19673979
[TBL] [Abstract][Full Text] [Related]
15. Patterns of failure following radiation with and without chemotherapy in patients with nasopharyngeal carcinoma.
Fuchs S; Rödel C; Brunner T; Iro H; Niedobitek G; Sauer R; Grabenbauer GG
Onkologie; 2003 Feb; 26(1):12-8. PubMed ID: 12624512
[TBL] [Abstract][Full Text] [Related]
16. Randomized clinical trial of post-operative radiotherapy versus concomitant carboplatin and radiotherapy for head and neck cancers with lymph node involvement.
Racadot S; Mercier M; Dussart S; Dessard-Diana B; Bensadoun RJ; Martin M; Malaurie E; Favrel V; Housset M; Durdux C; Journel C; Calais G; Huet J; Pillet G; Hennequin C; Haddad E; Diana C; Blaska-Jaulerry B; Henry-Amar M; Géhanno P; Baillet F; Mazeron JJ
Radiother Oncol; 2008 May; 87(2):164-72. PubMed ID: 18222010
[TBL] [Abstract][Full Text] [Related]
17. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.
Shao JY; Li YH; Gao HY; Wu QL; Cui NJ; Zhang L; Cheng G; Hu LF; Ernberg I; Zeng YX
Cancer; 2004 Mar; 100(6):1162-70. PubMed ID: 15022282
[TBL] [Abstract][Full Text] [Related]
18. [Infratemporal approach in nasopharyngeal cancer: operative technics and initial results].
Wolfensberger M; Fisch U
HNO; 1985 Jul; 33(7):307-10. PubMed ID: 4030414
[TBL] [Abstract][Full Text] [Related]
19. [Quantitative analysis of plasma Epstein-Barr virus (EBV) DNA for monitoring of recurrence and metastasis in nasopharyngeal carcinoma patients after radiotherapy].
Li YH; Shao JY; Zhao MQ; Gao HY; Li LR; Guan ZZ; Zeng YX
Ai Zheng; 2003 Jun; 22(6):645-8. PubMed ID: 12948418
[TBL] [Abstract][Full Text] [Related]
20. Pretherapy quantitative measurement of circulating Epstein-Barr virus DNA is predictive of posttherapy distant failure in patients with early-stage nasopharyngeal carcinoma of undifferentiated type.
Leung SF; Chan AT; Zee B; Ma B; Chan LY; Johnson PJ; Lo YM
Cancer; 2003 Jul; 98(2):288-91. PubMed ID: 12872347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
